This decision considers the liability or otherwise of a supplier of adaptors that enable access to broadcasts of the English Premier League that would otherwise have to purchased from a satellite or cable provider that has an arrangement with the… Read More ›
This Supreme Court Ruling clarifies that interim rulings regarding amendments to the application within the framework of an Opposition proceedings, are part of the opposition proceedings and can only be appealed immediately if authorization to appeal is given. After the… Read More ›
Mapi Pharma filed Israel Patent Application No. 220476 titled “Long Acting Depot System Comprising a Pharmaceutically Acceptable Salt of Glatiramer” which is used in the treatment of multiple sclerosis. The application is the national phase of a PCT submitted on 9… Read More ›
This trademark ruling concerns marks for Habitat in Hebrew and English. Habitat Design International had registered the English word-mark Habitat as a trademark in Israel. In 1976 Abraham Myerovitz opened a local store under the name הביטאט (Habitat in Hebrew) and… Read More ›
CAL Auto ltd submitted Trademark Application No. 272949 for their trademark in February 2015. The mark was allowed in November 2016, and on 19 January 2017, Israel Credit Cards ltd who trade under the term CAL and own various marks… Read More ›
On 2 November 2016, JS IP LLC applied for Israel TM NO. 296031 for the word mark LIV, covering Night club services; night clubs; arranging and conducting night club parties; entertainment services, namely, conducting parties; night club reservation services, namely, arranging… Read More ›
IL 198147 to PTC Therapeutics Inc is the national phase of a PCT application claiming priority from a US patent from 12 October 2006. The patent is concerned with dosages of 3-95-92-fluouro-phenyl)-[1,2,4]oxadiazol-3-yl)-benzoic acid (Altoran) for treating or preventing Cerebral Fibrosis… Read More ›
AMUSE LLC submitted Israel TM Application Number 266361 for the word-mark AMUSE SOCIETY in class 25. The Application was the national phase of international Trademark Application No. 1207555 filed under the Madrid Protocol. Ron Uziel represented by Kolodny Advocates opposed the… Read More ›
This decision is in response to a request to correct a faulty reporting that a registered design had lapsed due to a computer mistake at the Patent Office. The problem is that the Commissioner has no authority to reinstate lapsed… Read More ›
Pfizer, represented by Luzzatto, requested to amend the period of Patent Term Extension granted for IL 139110, under Section 170 of the Law which authorizes the Commissioner to adjust the Patent Register. The original patent was due to lapse on… Read More ›
